MedPath

Clinical Reporting to Alleviate the Nocebo Effect

Not Applicable
Active, not recruiting
Conditions
Nocebo Effect
Interventions
Diagnostic Test: Lumbar Magnetic Resonance Imaging (MRI)
Registration Number
NCT06103474
Lead Sponsor
University of Alabama at Birmingham
Brief Summary

Terminology in radiology reports may cause patients harm by anchoring to or justifying a particular diagnosis. This phenomenon is known as the nocebo effect. MRI may cause patients to pursue more invasive procedures with little added benefit. This study aims to reproduce a study to determine the impact of clinical reporting on patient care and outcomes for those suffering from lower back pain.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • History of lower back pain undergoing MRI
  • Greater than 18 years of age
  • Able to understand and willing to comply with all study procedures and is available for the duration of the study
Exclusion Criteria
  • A potential subject who meets any of the following criteria will be excluded from participation in the study:

    • Acute lower back pain secondary to trauma within 1 months
    • Severe cord compression on MRI
    • Cord signal abnormality on MRI
    • Metastatic cancer
    • Spinal epidural abscess
    • Vertebral osteomyelitis
    • Judgement of the ordering physician (e.g. focal neurologic deficit)
    • Anything that, in the opinion of the investigator or team, would place the subject at increased risk or preclude the subject's full compliance with or completion of the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard of Care ReportLumbar Magnetic Resonance Imaging (MRI)The subject will receive standard of care imaging report.
Clinical ReportLumbar Magnetic Resonance Imaging (MRI)The subject will receive a technical report that avoids language that may cause catastrophizing or evoke the nocebo effect.
Primary Outcome Measures
NameTimeMethod
Improvement of the visual analog scale (VAS) pain score in Clinical Report Cohort.within 7 days post intervention
Secondary Outcome Measures
NameTimeMethod
Improvement in pain interference measured via brief pain inventory6 weeks post intervention

Trial Locations

Locations (1)

UAB

🇺🇸

Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath